Hemolysis of erythrocytes by primary pharmacologic agents.
D000818:Animals; D001977:Brompheniramine / Q000494:pharmacology; D002707:Chlordiazepoxide / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D004155:Diphenhydramine / Q000494:pharmacology; D004315:Doxapram / Q000494:pharmacology; D004912:Erythrocytes / Q000187:drug effects*; D006460:Hemolysin Proteins / Q000494:pharmacology*; D006461:Hemolysis; D006801:Humans; D008721:Methocarbamol / Q000494:pharmacology; D009994:Osmolar Concentration; D010640:Phenothiazines / Q000494:pharmacology; D011395:Promazine / Q000494:pharmacology; D011817:Rabbits; D013329:Structure-Activity Relationship; D014043:Tolazoline / Q000494:pharmacology; D014294:Trimethaphan / Q000494:pharmacology
D006460:Hemolysin Proteins; D010640:Phenothiazines; D008721:Methocarbamol; D014294:Trimethaphan; D002707:Chlordiazepoxide; D004155:Diphenhydramine; D004315:Doxapram; D014043:Tolazoline; D001977:Brompheniramine; D011395:Promazine; D002746:Chlorpromazine